Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papp

Showing results (321-330 of 393) with videos related to

Pageof 40
Sort By:
British Journal of Pharmacology|August 22, 2006
Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodentsG Nowak, A Partyka, A Pałucha, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamaseKrisztina M Papp-Wallace, Magdalena Taracila, John M Hornick, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidimeKrisztina M Papp-Wallace, Marisa L Winkler, Julian A Gatta, et al.
Antimicrobial Agents and Chemotherapy|January 12, 2021
Structural and Biochemical Characterization of the Novel CTX-M-151 Extended-Spectrum β-Lactamase and Its Inhibition by AvibactamBarbara Ghiglione, María Margarita Rodríguez, Florencia Brunetti, et al.
Nature Communications|July 10, 2025
Enhancement of enzymatic activity by biomolecular condensates through pH bufferingF Stoffel, M Papp, M Gil-Garcia, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
The Effectiveness of Imipenem-Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-LactamaseKrisztina M Papp-Wallace, Melissa D Barnes, Magdalena A Taracila, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 13, 2022
Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatmentV Begni, I Pisano, M Marizzoni, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-LactamaseKrisztina M Papp-Wallace, Scott A Becka, Magdalena A Taracila, et al.
Current Microbiology|September 15, 2021
Effect of Serum Albumin, a Component of Human Pleural Fluid, on Transcriptional and Phenotypic Changes on Acinetobacter baumannii A118Casin Le, Camila Pimentel, Marisel R Tuttobene, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by AvibactamMichiyoshi Nukaga, Krisztina M Papp-Wallace, Tyuji Hoshino, et al.
Pageof 40

Showing results (321-330 of 393) with videos related to

Sort By:
Pageof 40
British Journal of Pharmacology|August 22, 2006
Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodentsG Nowak, A Partyka, A Pałucha, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamaseKrisztina M Papp-Wallace, Magdalena Taracila, John M Hornick, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2014
Reclaiming the efficacy of β-lactam-β-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidimeKrisztina M Papp-Wallace, Marisa L Winkler, Julian A Gatta, et al.
Antimicrobial Agents and Chemotherapy|January 12, 2021
Structural and Biochemical Characterization of the Novel CTX-M-151 Extended-Spectrum β-Lactamase and Its Inhibition by AvibactamBarbara Ghiglione, María Margarita Rodríguez, Florencia Brunetti, et al.
Nature Communications|July 10, 2025
Enhancement of enzymatic activity by biomolecular condensates through pH bufferingF Stoffel, M Papp, M Gil-Garcia, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
The Effectiveness of Imipenem-Relebactam against Ceftazidime-Avibactam Resistant Variants of the KPC-2 β-LactamaseKrisztina M Papp-Wallace, Melissa D Barnes, Magdalena A Taracila, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 13, 2022
Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatmentV Begni, I Pisano, M Marizzoni, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2015
Exposing a β-Lactamase "Twist": the Mechanistic Basis for the High Level of Ceftazidime Resistance in the C69F Variant of the Burkholderia pseudomallei PenI β-LactamaseKrisztina M Papp-Wallace, Scott A Becka, Magdalena A Taracila, et al.
Current Microbiology|September 15, 2021
Effect of Serum Albumin, a Component of Human Pleural Fluid, on Transcriptional and Phenotypic Changes on Acinetobacter baumannii A118Casin Le, Camila Pimentel, Marisel R Tuttobene, et al.
Antimicrobial Agents and Chemotherapy|February 15, 2018
Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by AvibactamMichiyoshi Nukaga, Krisztina M Papp-Wallace, Tyuji Hoshino, et al.
Pageof 40